Scholar Rock Holding (SRRK) Free Cash Flow (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Free Cash Flow came in at -$82.1 million in Q1 2026, down 4.04% year-on-year from -$85.6 million in Q1 2025, and down 8.75% quarter-over-quarter from -$75.5 million in Q4 2025.

Scholar Rock Holding (SRRK) Free Cash Flow (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$82.1 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 4.04% year-over-year to -$82.1 million in Q1 2026; TTM through Mar 2026 was -$303.8 million, a 31.8% decrease from a year earlier, with the FY2025 full-year figure at -$300.6 million, down 49.54% from the prior year.
  • Free Cash Flow retreated to -$82.1 million in Q1 2026 per SRRK's latest filing, from -$75.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$26.5 million in Q3 2022 and bottomed at -$82.1 million in Q1 2026.
  • The 5-year median for Free Cash Flow is -$49.5 million (2024), against an average of -$50.9 million.
  • Across the five-year window, Free Cash Flow rose 29.03% in 2022 and slumped 61.87% in 2024, its largest moves.
  • Year by year, Free Cash Flow stood at -$29.9 million in 2022, then slumped by 35.42% to -$40.4 million in 2023, then retreated by 24.2% to -$50.2 million in 2024, then sank by 50.4% to -$75.5 million in 2025, then decreased by 8.75% to -$82.1 million in 2026.
  • Per Business Quant, the three latest SRRK Free Cash Flow figures stand at -$82.1 million (Q1 2026), -$75.5 million (Q4 2025), and -$69.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -82.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.14 Mn
Mar 31, 2026 -82.14 Mn
Dec 31, 2025 -75.53 Mn
Dec 31, 2025 -75.53 Mn
Sep 30, 2025 -69.47 Mn
Sep 30, 2025 -69.47 Mn
Jun 30, 2025 -76.69 Mn
Jun 30, 2025 -76.69 Mn
Mar 31, 2025 -78.95 Mn
Mar 31, 2025 -78.95 Mn
Dec 31, 2024 -50.22 Mn
Dec 31, 2024 -50.22 Mn
Sep 30, 2024 -51.80 Mn
Sep 30, 2024 -51.80 Mn
Jun 30, 2024 -49.56 Mn
Jun 30, 2024 -49.56 Mn
Mar 31, 2024 -49.47 Mn
Mar 31, 2024 -49.47 Mn
Dec 31, 2023 -40.43 Mn
Dec 31, 2023 -40.43 Mn